“TAVR is a reasonable option for patients with aortic stenosis with outcomes similar to surgical aortic-valve replacement at seven years. There may be a signal for better survival in surgical aortic valve replacement.”
A Wed, study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: